| All deceased patients | 113 (100%) |
| Bleeding | 26 (23.0%) |
| Intracranial | 16 |
| Pulmonary | 3 |
| Other/unknown | 7 |
| Infection | 31 (27.4%) |
| Bacterial | 13 |
| Sepsis | 8∗ |
| Pneumonia | 4 |
| Meningitis | 2 |
| Fungal | 2† |
| Viral | 8‡ |
| Other/unknown | 8 |
| Malignancy | 8 (7.0%) |
| Lymphoma | 6§ |
| Leukemia | 2‖ |
| Autoimmunity | 4 (3.5%) |
| AIHA | 3 |
| Colitis | 1 |
| Directly HSCT related | 18 (15.9%) |
| GVHD | 5 |
| VOD | 3 |
| Infection | 9 |
| Organ toxicity | 3 |
| Other/unknown | 2 |
| Other/unknown¶ | 26 (23.0%) |
| All deceased patients | 113 (100%) |
| Bleeding | 26 (23.0%) |
| Intracranial | 16 |
| Pulmonary | 3 |
| Other/unknown | 7 |
| Infection | 31 (27.4%) |
| Bacterial | 13 |
| Sepsis | 8∗ |
| Pneumonia | 4 |
| Meningitis | 2 |
| Fungal | 2† |
| Viral | 8‡ |
| Other/unknown | 8 |
| Malignancy | 8 (7.0%) |
| Lymphoma | 6§ |
| Leukemia | 2‖ |
| Autoimmunity | 4 (3.5%) |
| AIHA | 3 |
| Colitis | 1 |
| Directly HSCT related | 18 (15.9%) |
| GVHD | 5 |
| VOD | 3 |
| Infection | 9 |
| Organ toxicity | 3 |
| Other/unknown | 2 |
| Other/unknown¶ | 26 (23.0%) |
In the first category, the leading cause of death is given. Numbers in the subcategories may not add up because some patients had multiple reported causes of death.
AIHA, autoimmune hemolytic anemia; B-NHL, B Non-Hodgkin lymphoma; CMV, cytomegalovirus; DLBCL, diffuse large B-cell lymphoma; GVHD, graft-versus-host disease; T-ALL, T acute lymphoblastic leukemia; VOD, veno-occlusive disease.
Two pneumococcus, other organisms not reported.
One aspergillus, 1 organism not reported.
Three CMV, 5 organisms not reported.
One B-NHL, 1 DLBCL, others not specified.
Two T-ALL, both GT asociated, both relapsed after HSCT.
Contains deaths that occurred >6 months after HSCT and were not clearly attributable to HSCT.